Pharma Foods International Co Ltd
TSE:2929
Pharma Foods International Co Ltd
Operating Income
Pharma Foods International Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pharma Foods International Co Ltd
TSE:2929
|
Operating Income
¥6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
47%
|
CAGR 10-Years
48%
|
|
GNI Group Ltd
TSE:2160
|
Operating Income
¥5.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Operating Income
¥6.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Operating Income
¥1.5B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-2%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Operating Income
-¥155.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
17%
|
S
|
StemRIM Inc
TSE:4599
|
Operating Income
¥142.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharma Foods International Co Ltd's Operating Income?
Operating Income
6B
JPY
Based on the financial report for Jan 31, 2024, Pharma Foods International Co Ltd's Operating Income amounts to 6B JPY.
What is Pharma Foods International Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
48%
The average annual Operating Income growth rates for Pharma Foods International Co Ltd have been 39% over the past three years , 47% over the past five years , and 48% over the past ten years .